SAB Biotherapeutics, Inc. Share Price

SAB Biotherapeutics, Inc. Share Price

NASDAQ: SABS | Micro Cap
$3.23
+$0.02 (0.47%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

SAB Biotherapeutics, Inc. Stock Performance

Open
$3.25
Prev. Close
$3.21
Circuit Range
N/A
Day Range
$3.18 - $3.34
Year Range
$2.44 - $5.12
Volume
40,493
Average Traded
$3.24

SAB Biotherapeutics, Inc. Share Price Today

As of 30 October 2026, SAB Biotherapeutics, Inc.'s share price is $3.23. The stock opened at $3.25, compared to its previous close of $3.21. During today's trading session, SAB Biotherapeutics, Inc.'s share price traded between $3.18 and $3.34, with an average price of $3.26. Over the past 52 weeks, the stock has recorded a high of $5.12 and a low of $2.44. In terms of performance, SAB Biotherapeutics, Inc.'s share price has declined by 13.40% over the last six months and is down 0.62% on a year-on-year basis.

SAB Biotherapeutics, Inc. Share Price Chart

Line chart of the SAB Biotherapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 3.17 to 3.35, ending at 3.23.
$3.18$3.34
L
Show Current Price
H

SAB Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$62.38M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.43
Revenue (TTM)
$0.00
Return On Equity (TTM)
-18.10%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-521.16%

SAB Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$5.34-$2.85-$18.87-$22.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-153.37%-562.11%-19.18%

SAB Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$23.90$2.24$1.32$0.00
Net Profit-$18.74-$42.19-$34.11$4.26
Net Profit Margin-78.41%-1883.48%-2584.09%N/A
Income ChangeN/A-125.13%19.15%112.49%

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

SAB Biotherapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.13
$3.23
+1.57%
Sep 2026
$3.70
$3.17
-19.01%
Aug 2026
$3.59
$3.92
+10.11%
Jul 2026
$3.90
$3.56
-8.72%
Jun 2026
$3.68
$3.90
+8.48%
May 2026
$3.73
$3.60
-3.62%
Apr 2026
$3.90
$3.73
-2.86%
Mar 2026
$3.98
$3.84
-6.20%
Feb 2026
$4.44
$4.09
-6.53%
Jan 2026
$3.77
$4.38
+17.43%
Dec 2025
$3.95
$3.73
-6.16%
Nov 2025
$3.19
$3.98
+22.31%

SABS Share Price FAQs